Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-22-014815
Filing Date
2022-10-04
Accepted
2022-10-04 09:07:44
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A tmb-20221004xdefa14a.htm DEFA14A 25258
2 GRAPHIC tmb-20221004xdefa14a001.jpg GRAPHIC 10740
  Complete submission text file 0001558370-22-014815.txt   41308
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

EIN.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35182 | Film No.: 221289849
SIC: 2834 Pharmaceutical Preparations